Skip to content
TrustList
GeneChem logo
Investor

GeneChem

Venture capital manager running specialist funds for biotechnology companies in North America and Europe

GeneChem cover

About GeneChem

GeneChem manages venture capital funds that concentrate on biotechnology. It has been investing since 1997, and the companies it has backed are based in the US, Canada and Europe. Its interest is in businesses that work on discovering and developing drugs.

What GeneChem offers

  • GeneChem Technologies — one of the four focused funds the firm operates.
  • GeneChem Therapeutics — a second fund in the same range, aimed at therapeutic companies.
  • Agechem — a further specialist fund managed by the firm.
  • AmorChem — the fourth fund in the group.

Who it works with

The firm invests in biotechnology companies involved in drug discovery and development. Its portfolio spans the United States, Canada and Europe.

Key facts

  • Investing since: 1997
  • Companies backed: more than 60
  • Funds: four, each with its own focus
  • Regions: US, Canada and Europe

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to GeneChem

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of GeneChem

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about GeneChem.

GeneChem alternatives

Similar listings buyers compare against this one.

Life-sciences investment firm covering healthcare, biotechnology, synthetic biology and technology

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Investment firm backing fintech companies that serve underserved people and small businesses in emerging markets